http://www.pluristem.com
Pluristem Therapeutics Inc. Company Intro
Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms
Industry
Healthcare
Pluristem Therapeutics Inc. Headquaters
Building No. 5
Haifa,31905
Israel
Pluristem Therapeutics Inc. Share price
17 May 2023 13:46 GMT
$0
0.0 (0 %)
Pluristem Therapeutics Inc. Market cap
$
WMC RANKING
2023
Pluristem Therapeutics Inc. # 325
BiotechnologyLatest Pluristem Therapeutics Inc. News
05 Dec 2023
Der Markt für aus Fettgewebe gewonnene Stammzelltherapie ...
... Pluristem Therapeutics, Cyagen, BioRestorative Therapies, Lonza, Pluristem Therapeutics, Celltex Therapeutics Corporation, iXCells Biotechnologies.
05 Dec 2023
Global Stem Cells Market Size, Market Disruptions and Future ...
... Inc, Pluristem Therapeutics Inc, OPEXA Therapeutics Inc, Seneca Biopharmaceuticals Inc, Caladrius, Mesoblast. The growth of the Global Stem Cells market is...
05 Dec 2023
Allogeneic Stem Cell Transplantation Market Size And ...
... Ltd., Pluristem Therapeutics Inc., Celularity Inc., Lineage Cell Therapeutics Inc., Nohla Therapeutics Inc., Orchard Therapeutics Plc. Request to Sample PDF...
WMC Market Score
WMC Market to Revenue Score
Pluristem Therapeutics Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Pluristem Therapeutics Inc. | USD | $0 | $44,551 | $-43,433 | $ | 325 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Pluristem Therapeutics Inc. Social Followers vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Post vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Pluristem Therapeutics Inc. | 0.00 | 5.82 | 0.03 | 0 | 0 | 0 | 2.52 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
